Skip to main content
. 2024 Jan 3;13(3):464–475. doi: 10.1002/psp4.13097

FIGURE 3.

FIGURE 3

PBPK model output from a simulation of 1000 term neonates aged 0–7 days receiving fosfomycin 100 mg/kg i.v. bolus q12h (a) and amikacin 15 mg/kg i.v. bolus q24h (b), with simulation data sampled every 5 min. The variable C max values are due, in part, to the simulated ontogeny and growth of each individual neonate over the simulation time period. C max, maximum plasma concentration; PBPK, physiologically‐based pharmacokinetic.